Watch a real patient and his family discuss their KYMRIAH journey.
KYMRIAH® (tisagenlecleucel): the first FDA-approved CAR-T cell therapy indicated for patients up to 25 years of age with relapsed or refractory B-cell ALL
KYMRIAH® (tisagenlecleucel): the first FDA-approved CAR-T cell therapy indicated for patients up to 25 years of age with relapsed or refractory B-cell ALL
Approved Use:
What is KYMRIAH?
KYMRIAH is a prescription cancer treatment used in patients up to 25 years old who have acute lymphoblastic leukemia (ALL) that has relapsed (went into remission, then came back) or is refractory (did not go into remission with other leukemia treatments). KYMRIAH is made from your own white blood cells.
KYMRIAH may cause side effects that are severe or life-threatening, such as cytokine release syndrome (CRS) and neurological toxicities. Call your health care provider or get emergency help right away if you get any of the following signs and symptoms of:
You may be admitted to the hospital, and treated with other medications, if you have CRS. If you are admitted to the hospital, tell the health care provider that you have received KYMRIAH.
Because of the risk of CRS, and neurological toxicities, KYMRIAH is only available through a restricted program under a Risk Evaluation and Mitigation Strategy (REMS) called the KYMRIAH REMS.
What are other serious side effects of KYMRIAH?
What are the most common side effects of KYMRIAH?
These are not all the possible side effects of KYMRIAH. Talk to your health care provider for medical advice about side effects.
What should I tell my health care provider before receiving KYMRIAH?
What should I be aware of after receiving KYMRIAH?
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
This is a summary of the most important safety information about KYMRIAH. Talk with your health care provider or pharmacist about side effects. If you would like more information, the FDA-approved product labeling for KYMRIAH can be found at www.KYMRIAH.com, or call 1-844-NVS-CART (1-844-687-2278).
Approved Use: What is KYMRIAH?
KYMRIAH is a prescription cancer treatment used in patients up to 25 years old who have acute lymphoblastic leukemia (ALL) that has relapsed (went in...
See MoreKYMRIAH may cause side effects that are severe or life-threatening, such as cytokine release syndrome (CRS) and neurological toxicities. Call your health care provider or...
See MoreKYMRIAH is available at select treatment centers across the United States. Click below to find the locations nearest to you.
Learn how KYMRIAH has worked in other children and young adults like you.